|
1
|
Kerr JF, Wyllie AH and Currie AR:
Apoptosis: A basic biological phenomenon with wide-ranging
implications in tissue kinetics. Br J Cancer. 26:239–257. 1972.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rogalińska M: Alterations in cell nuclei
during apoptosis. Cell Mol Biol Lett. 7:995–1018. 2002.
|
|
3
|
Galluzzi L, Vitale I, Aaronson SA, Abrams
JM, Adam D, Agostinis P, Alnemri ES, Altucci L, Amelio I, Andrews
DW, et al: Molecular mechanisms of cell death: Recommendations of
the Nomenclature Committee on Cell Death 2018. Cell Death Differ.
25:486–541. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tait SW and Green DR: Mitochondria and
cell death: Outer membrane permeabilization and beyond. Nat Rev Mol
Cell Biol. 11:621–632. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kalkavan H and Green DR: MOMP, cell
suicide as a BCL-2 family business. Cell Death Differ. 25:46–55.
2018. View Article : Google Scholar
|
|
6
|
Czabotar PE, Lessene G, Strasser A and
Adams JM: Control of apoptosis by the BCL-2 protein family:
Implications for physiology and therapy. Nat Rev Mol Cell Biol.
15:49–63. 2014. View Article : Google Scholar
|
|
7
|
Galluzzi L, Kepp O and Kroemer G:
Mitochondrial regulation of cell death: A phylogenetically
conserved control. Microb Cell. 3:101–108. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Moldoveanu T, Follis AV, Kriwacki RW and
Green DR: Many players in BCL-2 family affairs. Trends Biochem Sci.
39:101–111. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shamas-Din A, Kale J, Leber B and Andrews
DW: Mechanisms of action of Bcl-2 family proteins. Cold Spring Harb
Perspect Biol. 5:a0087142013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hardwick JM, Chen Y and Jonas EA:
Multipolar functions of BCL-2 proteins link energetics to
apoptosis. Trends Cell Biol. 22:318–328. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Pihán P, Carreras-Sureda A and Hetz C:
BCL-2 family: Integrating stress responses at the ER to control
cell demise. Cell Death Differ. 24:1478–1487. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang J and Ney PA: Role of BNIP3 and NIX
in cell death, autophagy, and mitophagy. Cell Death Differ.
16:939–946. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zamorano S, Rojas-Rivera D, Lisbona F,
Parra V, Court FA, Villegas R, Cheng EH, Korsmeyer SJ, Lavandero S
and Hetz C: A BAX/BAK and cyclophilin D-independent intrinsic
apoptosis pathway. PLoS One. 7:e377822012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kilbride SM and Prehn JH: Central roles of
apoptotic proteins in mitochondrial function. Oncogene.
32:2703–2711. 2013. View Article : Google Scholar
|
|
15
|
Parsons M and Green D: Mitochondria in
cell death. Essays Biochem. 47:99–114. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Korsmeyer SJ, Shutter JR, Veis DJ, Merry
DE and Oltvai ZN: BCL2/Bax: A rheostat that regulates an
anti-oxidant pathway and cell death. Semin Cancer Biol. 4:327–332.
1993.PubMed/NCBI
|
|
17
|
Abbate A, Bussani R, Amin MS, Vetrovec GW
and Baldi A: Acute myocardial infarction and heart failure: Role of
apoptosis. Int J Biochem Cell Biol. 38:1834–1840. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ahmad F, Lal H, Zhou J, Vagnozzi RJ, Yu
JE, Shang X, Woodgett JR, Gao E and Force T: Cardiomyocyte-specific
deletion of Gsk3α mitigates post-myocardial infarction remodeling,
contractile dysfunction, and heart failure. J Am Coll Cardiol.
64:696–706. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chinda K, Sanit J, Chattipakorn S and
Chattipakorn N: Dipeptidyl peptidase-4 inhibitor reduces infarct
size and preserves cardiac function via mitochondrial protection in
ischaemia-reperfusion rat heart. Diab Vasc Dis Res. 11:75–83. 2014.
View Article : Google Scholar
|
|
20
|
Gao CK, Liu H, Cui CJ, Liang ZG, Yao H and
Tian Y: Roles of MicroRNA-195 in cardiomyocyte apoptosis induced by
myocardial ischemia-reperfusion injury. J Genet. 95:99–108. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
World Health Organization (WHO): World
Health Statistics 2019: Monitoring health for the SDGs. WHO;
Geneva: 2019
|
|
22
|
Rajaleid K, Janszky I and Hallqvist J:
Small birth size, adult over-weight, and risk of acute myocardial
infraction. Epidemiology. 22:138–147. 2011. View Article : Google Scholar
|
|
23
|
Minamino T: Cardioprotection from
ischemia/reperfusion injury: Basic and translational research. Circ
J. 76:1074–1082. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li Z, Lu J, Luo Y, Li S and Chen M: High
association between human circulating microRNA-497 and acute
myocardial infarction. ScientificWorldJournal.
2014:9318452014.PubMed/NCBI
|
|
25
|
Eltzschig HK and Eckle T: Ischemia and
reperfusion-from mechanism to translation. Nat Med. 17:1391–1401.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jennings RB, Sommers HM, Smyth GA, Flack
HA and Linn H: Myocardial necrosis induced by temporary occlusion
of a coronary artery in the dog. Arch Pathol. 70:68–78.
1960.PubMed/NCBI
|
|
27
|
Bak MI and Ingwall JS: Contribution of
Na+/H+ exchange to Na+ overload in the ischemic hypertrophied
hyperthyroid rat heart. Cardiovasc Res. 57:1004–1014. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Murphy E and Steenbergen C: Mechanisms
underlying acute protection from cardiac ischemia-reperfusion
injury. Physiol Rev. 88:581–609. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Budhram-Mahadeo V, Fujita R, Bitsi S,
Sicard P and Heads R: Co-expression of POU4F2/Brn-3b with p53 may
be important for controlling expression of pro-apoptotic genes in
cardiomyocytes following ischaemic/hypoxic insults. Cell Death Dis.
5:e15032014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fröhlich GM, Meier P, White SK, Yellon DM
and Hausenloy DJ: Myocardial reperfusion injury: Looking beyond
primary PCI. Eur Heart J. 34:1714–1722. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chen S, Hua F, Lu J, Jiang Y, Tang Y, Tao
L, Zou B and Wu Q: Effect of dexmedetomidine on myocardial
ischemia-reperfusion injury. Int J Clin Exp Med. 8:21166–21172.
2015.
|
|
32
|
Moens AL, Claeys MJ, Timmermans JP and
Vrints CJ: Myocardial ischemia/reperfusion-injury, a clinical view
on a complex pathophysiological process. Int J Cardiol.
100:179–190. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu LF, Liang Z, Lv ZR, Liu XH, Bai J,
Chen J, Chen C and Wang Y: MicroRNA-15a/b are up-regulated in
response to myocardial ischemia/reperfusion injury. J Geriatr
Cardiol. 9:28–32. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Brown DI and Griendling KK: Regulation of
signal transduction by reactive oxygen species in the
cardiovascular system. Circ Res. 116:531–549. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kalogeris T, Baines CP, Krenz M and
Korthuis RJ: Ischemia/reperfusion. Compr Physiol. 7:113–170. 2016.
View Article : Google Scholar
|
|
36
|
Neri M, Riezzo I, Pascale N, Pomara C and
Turillazzi E: Ischemia/reperfusion injury following acute
myocardial infarction: A critical issue for clinicians and forensic
pathologists. Mediators Inflamm. 2017:70183932017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang X, Ha T, Zou J, Ren D, Liu L, Zhang
X, Kalbfleisch J, Gao X, Williams D and Li C: MicroRNA-125b
protects against myocardial ischaemia/reperfusion injury via
targeting p53-medi-ated apoptotic signalling and TRAF6. Cardiovasc
Res. 102:385–395. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
LeBaron TW, Kura B, Kalocayova B,
Tribulova N and Slezak J: A new approach for the prevention and
treatment of cardiovascular disorders. Molecular hydrogen
significantly reduces the effects of oxidative stress. Molecules.
24:20762019. View Article : Google Scholar :
|
|
39
|
Matsui Y, Takagi H, Qu X, Abdellatif M,
Sakoda H, Asano T, Levine B and Sadoshima J: Distinct roles of
autophagy in the heart during ischemia and reperfusion: Roles of
AMP-activated protein kinase and Beclin 1 in mediating autophagy.
Circ Res. 100:914–922. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Radomski MW, Palmer RM and Moncada S:
Endogenous nitric oxide inhibits human platelet adhesion to
vascular endothelium. Lancet. 2:1057–1058. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Xia Y and Zweier JL: Substrate control of
free radical generation from xanthine oxidase in the postischemic
heart. J Biol Chem. 270:18797–18803. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhang WP, Zong QF, Gao Q, Yu Y, Gu XY,
Wang Y, Li ZH and Ge M: Effects of endomorphin-1 postconditioning
on myocardial ischemia/reperfusion injury and myocardial cell
apoptosis in a rat model. Mol Med Rep. 14:3992–3998. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Liu L, Zhang G, Liang Z, Liu X, Li T, Fan
J, Bai J and Wang Y: MicroRNA-15b enhances
hypoxia/reoxygenation-induced apoptosis of cardiomyocytes via a
mitochondrial apoptotic pathway. Apoptosis. 19:19–29. 2014.
View Article : Google Scholar
|
|
44
|
Li CM, Shen SW, Wang T and Zhang XH:
Myocardial ischemic post-conditioning attenuates ischemia
reperfusion injury via PTEN/Akt signal pathway. Int J Clin Exp Med.
8:15801–15807. 2015.PubMed/NCBI
|
|
45
|
Liou SF, Ke HJ, Hsu JH, Liang JC, Lin HH,
Chen IJ and Yeh JL: San-Huang-Xie-Xin-Tang prevents rat hearts from
ischemia/reperfusion-induced apoptosis through eNOS and MAPK
pathways. Evid Based Complement Alternat Med. 2011:9150512011.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Chen Q and Lesnefsky EJ: Blockade of
electron transport during ischemia preserves bcl-2 and inhibits
opening of the mitochondrial permeability transition pore. FEBS
Lett. 585:921–926. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Chen Q, Xu H, Xu A, Ross T, Bowler E, Hu Y
and Lesnefsky EJ: Inhibition of Bcl-2 sensitizes mitochondrial
permeability transition pore (MPTP) opening in ischemia-damaged
mitochondria. PLoS One. 10:e01188342015. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Gustafsson AB and Gottlieb RA: Bcl-2
family members and apoptosis, taken to heart. Am J Physiol Cell
Physiol. 292:C45–C51. 2007. View Article : Google Scholar
|
|
49
|
Murphy E, Imahashi K and Steenbergen C:
Bcl-2 regulation of mitochondrial energetics. Trends Cardiovasc
Med. 15:283–290. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Qiao Z and Xu Y: Salvianolic acid b
alleviating myocardium injury in ischemia reperfusion rats. Afr J
Tradit Complement Altern Med. 13:157–161. 2016. View Article : Google Scholar
|
|
51
|
Zhang HY, McPherson BC, Liu H, Baman TS,
Rock P and Yao Z: H(2)O(2) opens mitochondrial K(ATP) channels and
inhibits GABA receptors via protein kinase C-epsilon in
cardiomyocytes. Am J Physiol Heart Circ Physiol. 282:H1395–H1403.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Meng G, Wang J, Xiao Y, Bai W, Xie L, Shan
L, Moore PK and Ji Y: GYY4137 protects against myocardial ischemia
and reperfusion injury by attenuating oxidative stress and
apoptosis in rats. J Biomed Res. 29:203–213. 2015.PubMed/NCBI
|
|
53
|
Song T, Wang P, Yu X, Wang A, Chai G, Fan
Y and Zhang Z: Systems analysis of phosphorylation-regulated Bcl-2
interactions establishes a model to reconcile the controversy over
the significance of Bcl-2 phosphorylation. Br J Pharmacol.
176:491–504. 2019. View Article : Google Scholar
|
|
54
|
Markou T, Dowling AA, Kelly T and Lazou A:
Regulation of Bcl-2 phosphorylation in response to oxidative stress
in cardiac myocytes. Free Radic Res. 43:809–816. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Syeda MZ, Fasae MB, Yue E, Ishimwe AP,
Jiang Y, Du Z, Yang B and Bai Y: Anthocyanidin attenuates
myocardial ischemia induced injury via inhibition of ROS-JNK-BCL2
pathway: New mechanism of anthocyanidin action. Phytother Res.
33:3129–3139. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Zhang Z, Deng X, Liu Y, Liu Y, Sun L and
Chen F: PKM2, function and expression and regulation. Cell Biosci.
9:522019. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Menon MB and Dhamija S: Beclin 1
Phosphorylation-at the center of autophagy regulation. Front Cell
Dev Biol. 6:1372018. View Article : Google Scholar
|
|
58
|
Wei Y, Sinha S and Levine B: Dual role of
JNK1-mediated phosphorylation of Bcl-2 in autophagy and apoptosis
regulation. Autophagy. 4:949–951. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Schulman D, Latchman DS and Yellon DM:
Urocortin protects the heart from reperfusion injury via
upregulation of p42/p44 MAPK signaling pathway. Am J Physiol Heart
Circ Physiol. 283:H1481–H1488. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Hausenloy DJ, Tsang A, Mocanu MM and
Yellon DM: Ischemic preconditioning protects by activating
prosurvival kinases at reperfusion. Am J Physiol Heart Circ
Physiol. 288:H971–H976. 2005. View Article : Google Scholar
|
|
61
|
Carter AN, Born HA, Levine AT, Dao AT,
Zhao AJ, Lee WL and Anderson AE: Wortmannin attenuates
seizure-induced hyperactive PI3K/Akt/mTOR signaling, impaired
memory, and spine dysmorphology in rats. eNeuro. 4. pp.
ENEURO.0354–16.2017. 2017, View Article : Google Scholar
|
|
62
|
Very N, Vercoutter-Edouart AS, Lefebvre T,
Hardivillé S and El Yazidi-Belkoura I: Cross-dysregulation of
O-GlcNAcylation and PI3K/AKT/mTOR axis in human chronic diseases.
Front Endocrinol (Lausanne). 9:6022018. View Article : Google Scholar
|
|
63
|
Chi Y, Ma Q, Ding XQ, Qin X, Wang C and
Zhang J: Research on protective mechanism of ibuprofen in
myocardial ischemia-reperfusion injury in rats through the
PI3K/Akt/mTOR signaling pathway. Eur Rev Med Pharmacol Sci.
23:4465–4473. 2019.PubMed/NCBI
|
|
64
|
Liang K, Ye Y, Wang Y, Zhang J and Li C:
Formononetin mediates neuroprotection against cerebral
ischemia/reperfusion in rats via downregulation of the Bax/BCL2
ratio and upregulation PI3K/Akt signaling pathway. J Neurol Sci.
344:100–104. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Yu LN, Yu J, Zhang FJ, Yang MJ, Ding TT,
Wang JK, He W, Fang T, Chen G and Yan M: Sevoflurane
postconditioning reduces myocardial reperfusion injury in rat
isolated hearts via activation of PI3K/Akt signaling and modulation
of Bcl-2 family proteins. J Zhejiang Univ Sci B. 11:661–672. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Zhang J, Wang C, Yu S, Luo Z, Chen Y, Liu
Q, Hua F, Xu G and Yu P: Sevoflurane postconditioning protects rat
hearts against ischemia-reperfusion injury via the activation of
PI3K/AKT/mTOR signaling. Sci Rep. 4:73172014. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Keyes KT, Xu J, Long B, Zhang C, Hu Z and
Ye Y: Pharmacological inhibition of PTEN limits myocardial infarct
size and improves left ventricular function postinfarction. Am J
Physiol Heart Circ Physiol. 298:H1198–H1208. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Zu L, Zheng X, Wang B, Parajuli N,
Steenbergen C, Becker LC and Cai ZP: Ischemic preconditioning
attenuates mitochondrial localization of PTEN induced by
ischemia-reperfusion. Am J Physiol Heart Circ Physiol.
300:H2177–H2186. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Zhu YB, Ding N, Yi HL and Li ZQ: The
expression of overexpressed PTEN enhanced IR-induced apoptosis of
myocardial cells. Eur Rev Med Pharmacol Sci. 23:4406–4413.
2019.PubMed/NCBI
|
|
70
|
Robinson MJ and Cobb MH: Mitogen-activated
protein kinase pathways. Curr Opin Cell Biol. 9:180–186. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Hernández-Reséndiz S, Roldán FJ, Correa F,
Martínez-Abundis E, Osorio-Valencia G, Ruíz-de-Jesús O,
Alexánderson-Rosas E, Vigueras RM, Franco M and Zazueta C:
Postconditioning protects against reperfusion injury in
hypertensive dilated cardiomyopathy by activating MEK/ERK1/2
signaling. J Card Fail. 19:135–146. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Holderfield M, Deuker MM, McCormick F and
McMahon M: Targeting RAF kinases for cancer therapy: BRAF-mutated
melanoma and beyond. Nat Rev Cancer. 14:455–467. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Balmanno K and Cook SJ: Tumour cell
survival signalling by the ERK1/2 pathway. Cell Death Differ.
16:368–377. 2009. View Article : Google Scholar
|
|
74
|
Zhou QL, Teng F, Zhang YS, Sun Q, Cao YX
and Meng GW: FPR1 gene silencing suppresses cardiomyocyte apoptosis
and ventricular remodeling in rats with ischemia/reperfusion injury
through the inhibition of MAPK signaling pathway. Exp Cell Res.
370:506–518. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Sun G, Ye N, Dai D, Chen Y, Li C and Sun
Y: The protective role of the TOPK/PBK pathway in myocardial
ischemia/reperfusion and H2O2-induced injury
in H9C2 cardiomyocytes. Int J Mol Sci. 17:2672016. View Article : Google Scholar
|
|
76
|
Sun MH, Chen XC, Han M, Yang YN, Gao XM,
Ma X, Huang Y, Li XM, Gai MT, Liu F, et al: Cardioprotective
effects of constitutively active MEK1 against
H2O2-induced apoptosis and autophagy in
cardiomyocytes via the ERK1/2 signaling pathway. Biochem Biophys
Res Commun. 512:125–130. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Lee ML, Sulistyowati E, Hsu JH, Huang BY,
Dai ZK, Wu BN, Chao YY and Yeh JL: KMUP-1 ameliorates
ischemia-induced cardiomyocyte apoptosis through the
NO−cGMP−MAPK signaling pathways. Molecules.
24:13762019. View Article : Google Scholar
|
|
78
|
Razavi HM, Hamilton JA and Feng Q:
Modulation of apoptosis by nitric oxide: Implications in myocardial
ischemia and heart failure. Pharmacol Ther. 106:147–162. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Burley DS, Ferdinandy P and Baxter GF:
Cyclic GMP and protein kinase-G in myocardial
ischaemia-reperfusion: Opportunities and obstacles for survival
signaling. Br J Pharmacol. 152:855–869. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Shvedova M, Anfinogenova Y,
Atochina-Vasserman EN, Schepetkin IA and Atochin DN: c-Jun
N-Terminal Kinases (JNKs) in myocardial and cerebral
ischemia/reperfusion injury. Front Pharmacol. 9:7152018. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Zhang W, Zhang Y, Ding K, Zhang H, Zhao Q,
Liu Z and Xu Y: Involvement of JNK1/2-NF-κBp65 in the regulation of
HMGB2 in myocardial ischemia/reperfusion-induced apoptosis in human
AC16 cardiomyocytes. Biomed Pharmacother. 106:1063–1071. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Wang Z, Huang H, He W, Kong B, Hu H, Fan
Y, Liao J, Wang L, Mei Y, Liu W, et al: Regulator of G-protein
signaling 5 protects cardiomyocytes against apoptosis during in
vitro cardiac ischemia-reperfusion in mice by inhibiting both
JNK1/2 and P38 signaling pathways. Biochem Biophys Res Commun.
473:551–557. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Chen Q, Xu T, Li D, Pan D, Wu P, Luo Y, Ma
Y and Liu Y: JNK/PI3K/Akt signaling pathway is involved in
myocardial ischemia/reperfusion injury in diabetic rats: Effects of
salvianolic acid A intervention. Am J Transl Res. 8:2534–2548.
2016.PubMed/NCBI
|
|
84
|
Frias MA and Montessuit C: JAK-STAT
signaling and myocardial glucose metabolism. JAKSTAT.
2:e264582013.
|
|
85
|
Harhous Z, Booz GW, Ovize M, Bidaux G and
Kurdi M: An update on the multifaceted roles of STAT3 in the heart.
Front Cardiovasc Med. 6:1502019. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Zhang WY, Zhang QL and Xu MJ: Effects of
propofol on myocardial ischemia reperfusion injury through
inhibiting the JAK/STAT pathway. Eur Rev Med Pharmacol Sci.
23:6339–6345. 2019.PubMed/NCBI
|
|
87
|
Bolli R, Dawn B and Xuan YT: Emerging role
of the JAK-STAT pathway as a mechanism of protection against
ischemia/reperfusion injury. J Mol Cell Cardiol. 33:1893–1896.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Liu Y, Che G, Di Z, Sun W, Tian J and Ren
M: Calycosin-7-O- β-D-glucoside attenuates myocardial
ischemia-reperfusion injury by activating JAK2/STAT3 signaling
pathway via the regulation of IL-10 secretion in mice. Mol Cell
Biochem. 463:175–187. 2020. View Article : Google Scholar
|
|
89
|
Bolli R, Dawn B and Xuan YT: Role of the
JAK-STAT pathway in protection against myocardial
ischemia/reperfusion injury. Trends Cardiovasc Med. 13:72–79. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Luan HF, Zhao ZB, Zhao QH, Zhu P, Xiu MY
and Ji Y: Hydrogen sulfide postconditioning protects isolated rat
hearts against ischemia and reperfusion injury mediated by the
JAK2/STAT3 survival pathway. Braz J Med Biol Res. 45:898–905. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Boengler K, Buechert A, Heinen Y, Roeskes
C, Hilfiker-Kleiner D, Heusch G and Schulz R: Cardioprotection by
ischemic post-conditioning is lost in aged and STAT3-deficient
mice. Circ Res. 102:131–135. 2008. View Article : Google Scholar
|
|
92
|
Lecour S: Activation of the protective
Survivor Activating Factor Enhancement (SAFE) pathway against
reperfusion injury: Does it go beyond the RISK pathway? J Mol Cell
Cardiol. 47:32–40. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Myers MG Jr: Cell biology. Moonlighting in
mitochondria. Science. 323:723–724. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Suleman N, Somers S, Smith R, Opie LH and
Lecour SC: Dual activation of STAT-3 and Akt is required during the
trigger phase of ischaemic preconditioning. Cardiovasc Res.
79:127–133. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Boengler K, Hilfiker-Kleiner D, Drexler H,
Heusch G and Schulz R: The myocardial JAK/STAT pathway: From
protection to failure. Pharmacol Ther. 120:172–185. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Bolli R, Stein AB, Guo Y, Wang OL, Rokosh
G, Dawn B, Molkentin JD, Sanganalmath SK, Zhu Y and Xuan YT: A
murine model of inducible, cardiac-specific deletion of STAT3: Its
use to determine the role of STAT3 in the upregulation of
cardioprotective proteins by ischemic preconditioning. J Mol Cell
Cardiol. 50:589–597. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Hattori R, Maulik N, Otani H, Zhu L,
Cordis G, Engelman RM, Siddiqui MA and Das DK: Role of STAT3 in
ischemic preconditioning. J Mol Cell Cardiol. 33:1929–1936. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Shen P, Chen J and Pan M: The protective
effects of total paeony glycoside on ischemia/reperfusion injury in
H9C2 cells via inhibition of the PI3K/Akt signaling pathway. Mol
Med Rep. 18:3332–3340. 2018.PubMed/NCBI
|
|
99
|
Koeppen M, Lee JW, Seo SW, Brodsky KS,
Kreth S, Yang IV, Buttrick PM, Eckle T and Eltzschig HK:
Hypoxia-inducible factor 2-alpha-dependent induction of
amphiregulin dampens myocardial ischemia-reperfusion injury. Nat
Commun. 9:8162018. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Li T, Yu J, Chen R, Wu J, Fei J, Bo Q, Xue
L and Li D: Mycophenolate mofetil attenuates myocardial
ischemia-reperfusion injury via regulation of the TLR4/NF-κB
signaling pathway. Pharmazie. 69:850–855. 2014.
|
|
101
|
Lin J, Wang H, Li J, Wang Q, Zhang S, Feng
N, Fan R and Pei J: κ-Opioid receptor stimulation modulates
TLR4/NF-κB signaling in the rat heart subjected to
ischemia-reperfusion. Cytokine. 61:842–848. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Li J, Xie C, Zhuang J, Li H, Yao Y, Shao C
and Wang H: Resveratrol attenuates inflammation in the rat heart
subjected to ischemia-reperfusion: Role of the TLR4/NF-κB signaling
pathway. Mol Med Rep. 11:1120–1126. 2015.
|
|
103
|
Gao Y, Song G, Cao YJ, Yan KP, Li B, Zhu
XF, Wang YP, Xing ZY, Cui L, Wang XX and Zhu MJ: The Guizhi Gancao
Decoction attenuates myocardial ischemia-reperfusion injury by
suppressing inflammation and cardiomyocyte apoptosis. Evid Based
Complement Alternat Med. 2019:19474652019. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Zhang N, Ye F, Zhu W, Hu D, Xiao C, Nan J,
Su S, Wang Y, Liu M, Gao K, et al: Cardiac ankyrin repeat protein
attenuates cardiomyocyte apoptosis by upregulation of Bcl-2
expression. Biochim Biophys Acta. 1863:3040–3049. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Ibrahim A: Inhibition of α-SMA, Bax and
increase of BCL2 expression in myocardiocytes as response to
chitosan administration to hypercholesterolemic rats. World J Pharm
Pharmac Sci. 5:164–176. 2016.
|
|
106
|
Guo J, Li HZ, Wang LC, Zhang WH, Li GW,
Xing WJ, Wang R and Xu CQ: Increased expression of calcium-sensing
receptors in atherosclerosis confers hypersensitivity to acute
myocardial infarction in rats. Mol Cell Biochem. 366:345–354. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Kuo WW, Hsu TC, Chain MH, Lai CH, Wang WH,
Tsai FJ, Tsai CH, Wu CH, Huang CY and Tzang BS: Attenuated cardiac
mitochondrial-dependent apoptotic effects by li-fu formula in
hamsters fed with a hypercholesterol diet. Evid Based Complement
Alternat Med. 2011:5303452011. View Article : Google Scholar :
|
|
108
|
Latif N, Khan MA, Birks E, O'Farrell A,
Westbrook J, Dunn MJ and Yacoub MH: Upregulation of the Bcl-2
family of proteins in end stage heart failure. J Am Coll Cardiol.
35:1769–1777. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Wang TD, Chen WJ, Su SS, Lo SC, Lin WW and
Lee YT: Increased cardiomyocyte apoptosis following ischemia and
reperfusion in diet-induced hypercholesterolemia: Relation to Bcl-2
and Bax proteins and caspase-3 activity. Lipids. 37:385–394. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Ye Y, Perez-Polo JR, Qian J and Birnbaum
Y: The role of microRNA in modulating myocardial
ischemia-reperfusion injury. Physiol Genomics. 43:534–542. 2011.
View Article : Google Scholar
|
|
111
|
Tang R, Long T, Lui KO, Chen Y and Huang
ZP: A roadmap for fixing the heart: RNA regulatory networks in
cardiac disease. Mol Ther Nucleic Acids. 20:673–686. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Kukreja RC, Yin C and Salloum FN:
MicroRNAs: New players in cardiac injury and protection. Mol
Pharmacol. 80:558–564. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Çakmak HA and Demir M: MicroRNA and
cardiovascular diseases. Balkan Med J. 37:60–71. 2020.PubMed/NCBI
|
|
114
|
Peterson SM, Thompson JA, Ufkin ML,
Sathyanarayana P, Liaw L and Congdon CB: Common features of
microRNA target prediction tools. Front Genet. 5:232014. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Cao L, Wang J and Wang PQ: MiR-326 is a
diagnostic biomarker and regulates cell survival and apoptosis by
targeting Bcl-2 in osteosarcoma. Biomed Pharmacother. 84:828–835.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Cheng Y, Tan N, Yang J, Liu X, Cao X, He
P, Dong X, Qin S and Zhang C: A translational study of circulating
cell-free microRNA-1 in acute myocardial infarction. Clin Sci
(Lond). 119:87–95. 2010. View Article : Google Scholar
|
|
117
|
Dehaini H, Awada H, El-Yazbi A, Zouein FA,
Issa K, Eid AA, Ibrahim M, Badran A, Baydoun E, Pintus G and Eid
AH: MicroRNAs as potential pharmaco-targets in ischemia-reperfusion
injury compounded by diabetes. Cells. 8:1522019. View Article : Google Scholar :
|
|
118
|
Yan H, Li Y, Wang C, Zhang Y, Liu C, Zhou
K and Hua Y: Contrary microRNA expression pattern between fetal and
adult cardiac remodeling: Therapeutic value for heart failure.
Cardiovasc Toxicol. 17:267–276. 2017. View Article : Google Scholar
|
|
119
|
Tang Y, Zheng J, Sun Y, Wu Z, Liu Z and
Huang G: MicroRNA-1 regulates cardiomyocyte apoptosis by targeting
Bcl-2. Int Heart J. 50:377–387. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Xie XJ, Fan DM, Xi K, Chen YW, Qi PW, Li
QH, Fang L and Ma LG: Suppression of microRNA-135b-5p protects
against myocardial ischemia/reperfusion injury by activating
JAK2/STAT3 signaling pathway in mice during sevoflurane anesthesia.
Biosci Rep. 37:BSR201701862017. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Hullinger TG, Montgomery RL, Seto AG,
Dickinson BA, Semus HM, Lynch JM, Dalby CM, Robinson K, Stack C,
Latimer PA, et al: Inhibition of miR-15 protects against cardiac
ischemic injury. Circ Res. 110:71–81. 2012. View Article : Google Scholar :
|
|
122
|
Liu X, Nie J and Li C: Targeted regulation
of Bcl 2 by miR-16 for cardiomyocyte apoptosis after cardiac
infarction. Int J Clin Exp Pathol. 10:4626–4632. 2017.
|
|
123
|
Yang W, Yang Y, Xia L, Yang Y, Wang F,
Song M, Chen X, Liu J, Song Y, Zhao Y and Yang C: MiR-221 promotes
Capan-2 pancreatic ductal adenocarcinoma cells proliferation by
targeting PTEN-Akt. Cell Physiol Biochem. 38:2366–2374. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Ye Z, Hao R, Cai Y, Wang X and Huang G:
Knockdown of miR-221 promotes the cisplatin-inducing apoptosis by
targeting the BIM-Bax/Bak axis in breast cancer. Tumour Biol.
37:4509–4515. 2016. View Article : Google Scholar
|
|
125
|
Kong QR, Ji DM, Li FR, Sun HY and Wang QX:
MicroRNA-221 promotes myocardial apoptosis caused by myocardial
ischemia-reperfusion by down-regulating PTEN. Eur Rev Med Pharmacol
Sci. 23:3967–3975. 2019.PubMed/NCBI
|
|
126
|
Li X, Zeng Z, Li Q, Xu Q, Xie J, Hao H,
Luo G, Liao W, Bin J, Huang X and Liao Y: Inhibition of
microRNA-497 ameliorates anoxia/reoxygenation injury in
cardiomyocytes by suppressing cell apoptosis and enhancing
autophagy. Oncotarget. 6:18829–18844. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Yang Q, Yang K and Li A: microRNA-21
protects against ischemia-reperfusion and
hypoxia-reperfusion-induced cardiocyte apoptosis via the
phosphatase and tensin homolog/Akt-dependent mechanism. Mol Med
Rep. 9:2213–2220. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Fan ZX and Yang J: The role of microRNAs
in regulating myocardial ischemia reperfusion injury. Saudi Med J.
36:787–793. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Yang J, Chen L, Yang J, Ding J, Li S, Wu
H, Zhang J, Fan Z, Dong W and Li X: MicroRNA-22 targeting CBP
protects against myocardial ischemia-reperfusion injury through
anti-apoptosis in rats. Mol Biol Rep. 41:555–561. 2014. View Article : Google Scholar
|
|
130
|
Yang J, Fan Z, Yang J, Ding J, Yang C and
Chen L: microRNA-22 attenuates myocardial ischemia-reperfusion
injury via an anti-inflammatory mechanism in rats. Exp Ther Med.
12:3249–3255. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Liu S, Yang Y, Song YQ, Geng J and Chen
QL: Protective effects of N(2)-L-alanyl-L-glutamine mediated by the
JAK2/STAT3 signaling pathway on myocardial ischemia reperfusion.
Mol Med Rep. 17:5102–5108. 2018.PubMed/NCBI
|
|
132
|
Xu D, Li H, Zhao Y and Wang C:
Downregulation of miR-34 a attenuates myocardial
ischemia/reperfusion injury by inhibiting cardiomyocyte apoptosis.
Int J Clin Exp Pathol. 10:3865–3875. 2017.
|
|
133
|
Kikuchi K and Poss KD: Cardiac
regenerative capacity and mechanisms. Annu Rev Cell Dev Biol.
28:719–741. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Biala AK and Kirshenbaum LA: The interplay
between cell death signaling pathways in the heart. Trends
Cardiovasc Med. 24:325–331. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
135
|
McCully JD, Wakiyama H, Hsieh YJ, Jones M
and Levitsky S: Differential contribution of necrosis and apoptosis
in myocardial ischemia-reperfusion injury. Am J Physiol Heart Circ
Physiol. 286:H1923–H1935. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Mocanu MM, Baxter GF and Yellon DM:
Caspase inhibition and limitation of myocardial infarct size:
Protection against lethal reperfusion injury. Br J Pharmacol.
130:197–200. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Baxter G, Mocanu M, Brar B, Latchman D and
Yellon D: Cardioprotective effects of transforming growth
factor-beta1 during early reoxygenation or reperfusion are mediated
by p42/p44 MAPK. J Cardiovasc Pharmacol. 38:930–939. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Yellon DM and Baxter GF: Reperfusion
injury revisited: Is there a role for growth factor signaling in
limiting lethal reperfusion injury? Trends Cardiovasc Med.
9:245–249. 1999. View Article : Google Scholar
|
|
139
|
Davidson SM, Ferdinandy P, Andreadou I,
Bøtker HE, Heusch G, Ibáñez B, Ovize M, Schulz R, Yellon DM,
Hausenloy DJ, et al: Multitarget strategies to reduce myocardial
ischemia/reperfusion injury: JACC review topic of the week. J Am
Coll Cardiol. 73:89–99. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Soares ROS, Losada DM, Jordani MC, Évora P
and Castro-E-Silva O: Ischemia/reperfusion injury revisited: An
overview of the latest pharmacological strategies. Int J Mol Sci.
20:50342019. View Article : Google Scholar :
|
|
141
|
Euler G: Good and bad sides of
TGFβ-signaling in myocardial infarction. Front Physiol. 6:662015.
View Article : Google Scholar
|
|
142
|
Yellon DM and Hausenloy DJ: Myocardial
reperfusion injury. N Engl J Med. 357:1121–1135. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Mykytenko J, Kerendi F, Reeves JG, Kin H,
Zatta AJ, Jiang R, Guyton RA, Vinten-Johansen J and Zhao ZQ:
Long-term inhibition of myocardial infarction by postconditioning
during reperfusion. Basic Res Cardiol. 102:90–100. 2007. View Article : Google Scholar
|
|
144
|
Argaud L, Gateau-Roesch O, Raisky O,
Loufouat J, Robert D and Ovize M: Postconditioning inhibits
mitochondrial permeability transition. Circulation. 111:194–197.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Pagliaro P, Femminò S, Popara J and Penna
C: Mitochondria in cardiac postconditioning. Front Physiol.
9:2872018. View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Heusch G: Critical issues for the
translation of cardioprotection. Circ Res. 120:1477–1486. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
147
|
Heusch G: Cardioprotection research must
leave its comfort zone. Eur Heart J. 39:3393–3395. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Hausenloy DJ, Botker HE, Engstrom T,
Erlinge D, Heusch G, Ibanez B, Kloner RA, Ovize M, Yellon DM and
Garcia-Dorado D: Targeting reperfusion injury in patients with
ST-segment elevation myocardial infarction: Trials and
tribulations. Eur Heart J. 38:935–941. 2017.
|
|
149
|
Ferdinandy P, Hausenloy DJ, Heusch G,
Baxter GF and Schulz R: Interaction of risk factors, comorbidities,
and comedications with ischemia/reperfusion injury and
cardioprotection by preconditioning, postconditioning, and remote
conditioning. Pharmacol Rev. 66:1142–1174. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
150
|
Hausenloy DJ, Garcia-Dorado D, Bøtker HE,
Davidson SM, Downey J, Engel FB, Jennings R, Lecour S, Leor J,
Madonna R, et al: Novel targets and future strategies for acute
cardioprotection: Position paper of the European Society of
Cardiology Working Group on Cellular Biology of the Heart.
Cardiovasc Res. 113:564–585. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Inserte J, Hernando V, Vilardosa Ú, Abad
E, Poncelas-Nozal M and Garcia/Dorado D: Activation of cGMP/protein
kinase G pathway in postconditioned myocardium depends on reduced
oxidative Stress and preserved endothelial nitric oxide synthase
coupling. J Am Heart Assoc. 2:e0059752013. View Article : Google Scholar : PubMed/NCBI
|
|
152
|
Kleinbongard P, Skyschally A and Heusch G:
Cardioprotection by remote ischemic conditioning and its signal
transduction. Pflugers Arch. 469:159–181. 2017. View Article : Google Scholar
|
|
153
|
Heusch G: Molecular basis of
cardioprotection: Signal transduction in ischemic pre-, post-, and
remote conditioning. Circ Res. 116:674–699. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
154
|
Murry CE, Jennings RB and Reimer KA:
Preconditioning with ischemia: A delay of lethal cell injury in
ischemic myocardium. Circulation. 74:1124–1136. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Wever KE, Hooijmans CR, Riksen NP,
Sterenborg TB, Sena ES, Ritskes-Hoitinga M and Warlé MC:
Determinants of the efficacy of cardiac ischemic preconditioning: A
systematic review and meta-analysis of animal studies. PLoS One.
10:e01420212015. View Article : Google Scholar : PubMed/NCBI
|
|
156
|
Wever KE, Menting TP, Rovers M, van der
Vliet JA, Rongen GA, Masereeuw R, Ritskes-Hoitinga M, Hooijmans CR
and Warlé M: Ischemic preconditioning in the animal kidney, a
systematic review and meta-analysis. PLoS One. 7:e322962012.
View Article : Google Scholar : PubMed/NCBI
|
|
157
|
Yellon DM, Alkhulaifi AM and Pugsley WB:
Preconditioning the human myocardium. Lancet. 342:276–277. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
158
|
Rossello X and Yellon DM: The RISK pathway
and beyond. Basic Res Cardiol. 113:22017. View Article : Google Scholar : PubMed/NCBI
|
|
159
|
Hausenloy DJ, Barrabes JA, Bøtker HE,
Davidson SM, Di Lisa F, Downey J, Engstrom T, Ferdinandy P,
Carbrera-Fuentes HA, Heusch G, et al: Ischaemic conditioning and
targeting reperfusion injury: A 30 year voyage of discovery. Basic
Res Cardiol. 111:702016. View Article : Google Scholar
|
|
160
|
Sun XJ and Mao JR: Role of Janus kinase
2/signal transducer and activator of transcription 3 signaling
pathway in cardioprotection of exercise preconditioning. Eur Rev
Med Pharmacol Sci. 22:4975–4986. 2018.PubMed/NCBI
|
|
161
|
Duan W, Yang Y, Yan J, Yu S, Liu J, Zhou
J, Zhang J, Jin Z and Yi D: The effects of curcumin post-treatment
against myocardial ischemia and reperfusion by activation of the
JAK2/STAT3 signaling pathway. Basic Res Cardiol. 107:2632012.
View Article : Google Scholar : PubMed/NCBI
|
|
162
|
Goodman MD, Koch SE, Afzal MR and Butler
KL: STAT subtype specificity and ischemic preconditioning in mice:
Is STAT-3 enough? Am J Physiol Heart Circ Physiol. 300:H522–H526.
2011. View Article : Google Scholar :
|
|
163
|
Dawn B, Xuan YT, Guo Y, Rezazadeh A, Stein
AB, Hunt G, Wu WJ, Tan W and Bolli R: IL-6 plays an obligatory role
in late preconditioning via JAK-STAT signaling and upregulation of
iNOS and COX-2. Cardiovasc Res. 64:61–71. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
164
|
Xuan YT, Guo Y, Zhu Y, Wang OL, Rokosh G,
Messing RO and Bolli R: Role of the protein kinase
C-epsilon-Raf-1-MEK-1/2-p44/42 MAPK signaling cascade in the
activation of signal transducers and activators of transcription 1
and 3 and induction of cyclooxygenase-2 after ischemic
preconditioning. Circulation. 112:1971–1978. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
165
|
Chen TI, Shen YJ, Wang IC and Yang KT:
Short-term exercise provides left ventricular myocardial protection
against intermit-tent hypoxia-induced apoptosis in rats. Eur J Appl
Physiol. 111:1939–1950. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
166
|
Zhao ZQ, Corvera JS, Halkos ME, Kerendi F,
Wang NP, Guyton RA and Vinten-Johansen J: Inhibition of myocardial
injury by ischemic postconditioning during reperfusion: Comparison
with ischemic preconditioning. Am J Physiol Heart Circ Physiol.
285:H579–H588. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
167
|
Thibault H, Piot C, Staat P, Bontemps L,
Sportouch C, Rioufol G, Cung TT, Bonnefoy E, Angoulvant D, Aupetit
JF, et al: Long-term benefit of postconditioning. Circulation.
117:1037–1044. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
168
|
Zhao CM, Yang XJ, Yang JH, Cheng XJ, Zhao
X, Zhou BY, Xu SD and Wang HF: Effect of ischaemic postconditioning
on recovery of left ventricular contractile function after acute
myocardial infarction. J Int Med Res. 40:1082–1088. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
169
|
Tian Y, Zhang W, Xia D, Modi P, Liang D
and Wei M: Postconditioning inhibits myocardial apoptosis during
prolonged reperfusion via a AK2-STAT3-BCL2 pathway. J Biomed Sci.
18:532011. View Article : Google Scholar
|
|
170
|
Shyu WC, Lin SZ, Chiang MF, Chen DC, Su
CY, Wang HJ, Liu RS, Tsai CH and Li H: Secretoneurin promotes
neuroprotection and neuronal plasticity via the Jak2/Stat3 pathway
in murine models of stroke. J Clin Invest. 118:133–148. 2008.
View Article : Google Scholar
|
|
171
|
Siddiquee K, Zhang S, Guida WC, Blaskovich
MA, Greedy B, Lawrence HR, Yip ML, Jove R, McLaughlin MM, Lawrence
NJ, et al: Selective chemical probe inhibitor of Stat3, identified
through structure-based virtual screening, induces antitumor
activity. Proc Natl Acad Sci USA. 104:7391–7396. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
172
|
Hausenloy DJ, Tsang A and Yellon DM: The
reperfusion injury salvage kinase pathway: A common target for both
ischemic preconditioning and postconditioning. Trends Cardiovasc
Med. 15:69–75. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
173
|
Jin YC, Lee YS, Kim YM, Seo HG, Lee JH,
Kim HJ, Yun-Choi HS and Chang KC:
(S)-1-(alpha-naphthylmethyl)-6,7-di
hydroxy-1,2,3,4-tetrahydroisoquinoline (CKD712) reduces rat
myocardial apoptosis against ischemia and reperfusion injury by
activation of phosphatidylinositol 3-kinase/Akt signaling and
anti-inflammatory action in vivo. J Pharmacol Exp Ther.
330:440–448. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
174
|
Takahama H, Minamino T, Hirata A, Ogai A,
Asanuma H, Fujita M, Wa keno M, Tsukamoto O, Okada K, Komamura K,
et al: Granulocyte colony-stimulating factor mediates
cardioprotection against ischemia/reperfusion injury via
phosphatidylinositol-3-kinase/Akt pathway in canine hearts.
Cardiovasc Drugs Ther. 20:159–165. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
175
|
Goodman MD, Koch SE, Fuller-Bicer GA and
Butler KL: Regulating RISK: A role for JAK-STAT signaling in
postconditioning? Am J Physiol Heart Circ Physiol. 295:H1649–H1656.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
176
|
Wu N, Zhang X, Jia P and Jia D:
Hypercholesterolemia aggravates myocardial ischemia reperfusion
injury via activating endoplasmic reticulum stress-mediated
apoptosis. Exp Mol Pathol. 99:449–454. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
177
|
Luo T, Zeng X, Yang W and Zhang Y:
Treatment with metformin prevents myocardial ischemia-reperfusion
injury via STEAP4 signaling pathway. Anatol J Cardiol. 21:261–271.
2019.PubMed/NCBI
|
|
178
|
Hu M, Ye P, Liao H, Chen M and Yang F:
Metformin protects H9C2 cardiomyocytes from high-glucose and
hypoxia/reoxygenation injury via inhibition of reactive oxygen
species generation and inflammatory responses: Role of AMPK and
JNK. J Diabetes Res. 2016:29619542016. View Article : Google Scholar : PubMed/NCBI
|
|
179
|
Kahn BB, Alquier T, Carling D and Hardie
DG: AMP-activated protein kinase: Ancient energy gauge provides
clues to modern understanding of metabolism. Cell Metab. 1:15–25.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
180
|
Wang Y, Liu J, Ma A and Chen Y:
Cardioprotective effect of berberine against myocardial
ischemia/reperfusion injury via attenuating mitochondrial
dysfunction and apoptosis. Int J Clin Exp Med. 8:14513–14519.
2015.PubMed/NCBI
|
|
181
|
Wang Y, Zhang H, Chai F, Liu X and Berk M:
The effects of escitalopram on myocardial apoptosis and the
expression of Bax and BCL2 during myocardial ischemia/reperfusion
in a model of rats with depression. BMC Psychiatry. 14:3492014.
View Article : Google Scholar
|
|
182
|
Zhang SW, Liu Y, Wang F, Qiang J, Liu P,
Zhang J and Xu JW: Ilexsaponin A attenuates
ischemia-reperfusion-induced myocardial injury through
anti-apoptotic pathway. PLoS One. 12:e01709842017. View Article : Google Scholar : PubMed/NCBI
|
|
183
|
Cheng X, Hu J, Wang Y, Ye H, Li X, Gao Q
and Li Z: Effects of dexmedetomidine postconditioning on myocardial
ischemia/reperfusion injury in diabetic rats: Role of the
PI3K/Akt-dependent signaling pathway. J Diabetes Res.
2018:30719592018. View Article : Google Scholar : PubMed/NCBI
|
|
184
|
Morris RE: Prevention and treatment of
allograft rejection in vivo by rapamycin: Molecular and cellular
mechanisms of action. Ann N Y Acad Sci. 685:68–72. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
185
|
Menown IBA, Mamas MA, Cotton JM,
Hildick-Smith D, Eberli FR, Leibundgut G, Tresukosol D, Macaya C,
Copt S, Sadozai Slama S and Stoll HP: First clinical evidence
characterizing safety and efficacy of the new CoCr Biolimus-A9
eluting stent: The Biomatrix Alpha™ registry. Int J Cardiol Heart
Vasc. 26:1004722020.
|
|
186
|
Das A, Salloum FN, Durrant D, Ockaili R
and Kukreja RC: Rapamycin protects against myocardial
ischemia-reperfusion injury through JAK2-STAT3 signaling pathway. J
Mol Cell Cardiol. 53:858–869. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
187
|
Filippone SM, Samidurai A, Roh SK, Cain
CK, He J, Salloum FN, Kukreja RC and Das A: Reperfusion therapy
with rapamycin attenuates myocardial infarction through activation
of AKT and ERK. Oxid Med Cell Longev. 2017:46197202017. View Article : Google Scholar : PubMed/NCBI
|
|
188
|
Zhai M, Li B, Duan W, Jing L, Zhang B,
Zhang M, Yu L, Liu Z, Yu B, Ren K, et al: Melatonin ameliorates
myocardial ischemia reperfusion injury through SIRT3-dependent
regulation of oxidative stress and apoptosis. J Pineal Res.
63:2017. View Article : Google Scholar
|
|
189
|
Hsu CP, Zhai P, Yamamoto T, Maejima Y,
Matsushima S, Hariharan N, Shao D, Takagi H, Oka S and Sadoshima J:
Silent information regulator 1 protects the heart from
ischemia/reperfusion. Circulation. 122:2170–2182. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
190
|
Yu L, Sun Y, Cheng L, Jin Z, Yang Y, Zhai
M, Pei H, Wang X, Zhang H, Meng Q, et al: Melatonin
receptor-mediated protection against myocardial
ischemia/reperfusion injury: Role of SIRT1. J Pineal Res.
57:228–238. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
191
|
Hardi DG: Keeping the home fires burning:
AMP-activated protein kinase. J R Soc Interface. 15:201707742018.
View Article : Google Scholar
|
|
192
|
Zhang M, Zhao Z, Shen M, Zhang Y, Duan J,
Guo Y, Zhang D, Hu J, Lin J, Man W, et al: Polydatin protects
cardiomyocytes against myocardial infarction injury by activating
Sirt3. Biochim Biophys Acta Mol Basis Dis. 1863:1962–1972. 2017.
View Article : Google Scholar
|
|
193
|
Yu L, Gong B, Duan W, Fan C, Zhang J, Li
Z, Xue X, Xu Y, Meng D, Li B, et al: Melatonin ameliorates
myocardial ischemia/reperfusion injury in type 1 diabetic rats by
preserving mitochondrial function: Role of AMPK-PGC-1α-SIRT3
signaling. Sci Rep. 7:413372017. View Article : Google Scholar
|
|
194
|
Yu L, Liang H, Lu Z, Zhao G, Zhai M, Yang
Y, Yang J, Yi D, Chen W, Wang X, et al: Membrane receptor-dependent
Notch1/Hes1 activation by melatonin protects against myocardial
ischemia-reperfusion injury: In vivo and in vitro studies. J Pineal
Res. 59:420–433. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
195
|
Heusch G: Myocardial ischaemia-reperfusion
injury and cardio-protection in perspective. Nat Rev Cardiol. Jul
3–2020.Epub ahead of print. View Article : Google Scholar
|
|
196
|
Gross A and Katz SG: Non-apoptotic
functions of BCL-2 family proteins. Cell Death Differ.
24:1348–1358. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
197
|
Chiu WT, Chang HA, Lin YH, Lin YS, Chang
HT, Lin HH, Huang SC, Tang MJ and Shen MR: Bcl-2 regulates
store-operated Ca2+ entry to modulate ER stress-induced
apoptosis. Cell Death Discov. 4:372018. View Article : Google Scholar
|
|
198
|
Bonneau B, Prudent J, Popgeorgiev N and
Gillet G: Non-apoptotic roles of Bcl-2 family: The calcium
connection. Biochim Biophys Acta. 1833:1755–176. 2013. View Article : Google Scholar : PubMed/NCBI
|
